The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers - Ipsos
The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers - Ipsos

The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers

Early-stage immunotherapy: turn the perioperative "black box" into a clear path to ROI.
Cover of the Perioperative Pivout POV from Ipsos

Immune checkpoint inhibitors (PD 1/PD L1) are moving into perioperative (neoadjuvant/adjuvant) care for early-stage solid tumours. This shift is an opportunity - and a strategic black box.

In this Point of View, Ipsos’ experts decode the new perioperative landscape and offer a practical plan for clinical and commercial impact. Grounded in our therapy area experience and a new Ipsos survey of US based medical oncologists, the paper addresses three pressing questions:

  • How to align on a consistent definition of “high-risk” patients across the multidisciplinary care team.
  • How to translate event-free and disease-free survival into clear value stories for stakeholders beyond medical oncology.
  • How to fix handoff gaps between diagnosis, surgery, and systemic treatment so eligible patients stay on pathway.

Read to look ahead and delve into the perioperative pivot for immuno-oncology.
 

The author(s)

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.